Assura (LON:AGR) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Assura Plc (LON:AGRGet Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 48.37 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares trading hands.

Analyst Ratings Changes

A number of research analysts have recently commented on AGR shares. Shore Capital reissued a “hold” rating on shares of Assura in a report on Wednesday, October 1st. Peel Hunt reaffirmed a “buy” rating and set a GBX 60 target price on shares of Assura in a research report on Tuesday, September 30th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of GBX 60.

Read Our Latest Stock Report on AGR

Assura Price Performance

The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The company has a market cap of £1.54 billion, a price-to-earnings ratio of 895.85, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a fifty day moving average price of GBX 47.48 and a two-hundred day moving average price of GBX 48.37.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Featured Stories

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.